| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | ZNF567 ZNF212 MAX TRPS1 MECOM ZBTB12 ZNF25 ZNF568 ZNF284 ZNF10 ZNF677 NCOR1 ZNF23 ZNF547 ZNF33B ZNF852 ZNF408 CARF ZNF483 ZNF432 ZNF534 ZNF578 ZNF701 ZNF84 ZNF468 ZKSCAN4 ZNF319 ZNF709 ZNF682 ZNF304 | 1.01e-10 | 1459 | 108 | 30 | GO:0000977 |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | ZNF567 ZNF212 MAX MECOM ZBTB12 ZNF568 ZNF284 ZNF677 ZNF23 ZNF547 ZNF33B ZNF852 MTOR ZNF408 CARF ZNF483 ZNF432 ZNF534 ZNF578 ZNF701 ZNF84 ZNF468 ZKSCAN4 ZNF319 ZNF709 ZNF682 ZNF304 | 5.41e-10 | 1271 | 108 | 27 | GO:0000987 |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | ZNF212 MAX TRPS1 MECOM ZBTB12 ZNF25 ZNF568 ZNF284 ZNF10 ZNF677 ZNF23 ZNF547 ZNF33B ZNF852 ZNF408 CARF ZNF483 ZNF432 ZNF534 ZNF578 ZNF701 ZNF84 ZNF468 ZKSCAN4 ZNF319 ZNF709 ZNF682 ZNF304 | 1.14e-09 | 1412 | 108 | 28 | GO:0000981 |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | ZNF567 ZNF212 MAX MECOM ZBTB12 ZNF568 ZNF284 ZNF677 ZNF23 ZNF547 ZNF33B ZNF852 ZNF408 CARF ZNF483 ZNF432 ZNF534 ZNF578 ZNF701 ZNF84 ZNF468 ZKSCAN4 ZNF319 ZNF709 ZNF682 ZNF304 | 1.72e-09 | 1244 | 108 | 26 | GO:0000978 |
| GeneOntologyMolecularFunction | cytoskeleton-nuclear membrane anchor activity | 2.87e-04 | 5 | 108 | 2 | GO:0140444 | |
| Domain | KRAB | ZNF567 ZNF212 ZNF25 ZNF568 ZNF284 ZNF10 ZNF677 ZNF23 ZNF547 ZNF33B ZNF852 ZNF483 ZNF432 ZNF534 ZNF578 ZNF701 ZNF84 ZNF468 ZKSCAN4 ZNF709 ZNF282 ZNF682 ZNF304 | 4.13e-18 | 358 | 106 | 23 | PS50805 |
| Domain | KRAB | ZNF567 ZNF212 ZNF25 ZNF568 ZNF284 ZNF10 ZNF677 ZNF23 ZNF547 ZNF33B ZNF852 ZNF483 ZNF432 ZNF534 ZNF578 ZNF701 ZNF84 ZNF468 ZKSCAN4 ZNF709 ZNF282 ZNF682 ZNF304 | 8.07e-18 | 369 | 106 | 23 | SM00349 |
| Domain | KRAB | ZNF567 ZNF212 ZNF25 ZNF568 ZNF284 ZNF10 ZNF677 ZNF23 ZNF547 ZNF33B ZNF852 ZNF483 ZNF432 ZNF534 ZNF578 ZNF701 ZNF84 ZNF468 ZKSCAN4 ZNF709 ZNF282 ZNF682 ZNF304 | 8.57e-18 | 370 | 106 | 23 | IPR001909 |
| Domain | zf-C2H2 | ZNF567 ZNF212 TRPS1 MECOM ZBTB12 ZNF25 ZNF568 ZNF284 ZNF10 ZNF677 ZNF23 ZNF547 ZNF33B ZNF852 ZNF592 ZNF408 ZNF483 ZNF432 ZNF534 ZNF578 ZNF701 ZNF84 ZNF468 ZKSCAN4 ZNF319 ZNF709 ZNF282 ZNF682 ZNF304 | 1.11e-17 | 693 | 106 | 29 | PF00096 |
| Domain | ZINC_FINGER_C2H2_1 | ZNF567 ZNF212 TRPS1 MECOM ZBTB12 ZNF25 ZNF568 ZNF284 ZNF10 ZNF677 ZNF23 ZNF547 ZNF33B ZNF852 ZNF592 ZNF408 ZNF483 CIZ1 ZNF432 ZNF534 ZNF578 ZNF701 ZNF84 ZNF468 ZKSCAN4 ZNF319 ZNF709 ZNF282 ZNF682 ZNF304 | 2.47e-17 | 777 | 106 | 30 | PS00028 |
| Domain | Znf_C2H2-like | ZNF567 ZNF212 TRPS1 MECOM ZBTB12 ZNF25 ZNF568 ZNF284 ZNF10 ZNF677 ZNF23 ZNF547 ZNF33B ZNF852 ZNF592 ZNF408 ZNF483 CIZ1 ZNF432 ZNF534 ZNF578 ZNF701 ZNF84 ZNF468 ZKSCAN4 ZNF319 ZNF709 ZNF282 ZNF682 ZNF304 | 4.77e-17 | 796 | 106 | 30 | IPR015880 |
| Domain | KRAB | ZNF567 ZNF212 ZNF25 ZNF568 ZNF284 ZNF10 ZNF677 ZNF547 ZNF33B ZNF852 ZNF483 ZNF432 ZNF534 ZNF578 ZNF701 ZNF84 ZNF468 ZKSCAN4 ZNF709 ZNF282 ZNF682 ZNF304 | 6.16e-17 | 358 | 106 | 22 | PF01352 |
| Domain | Znf_C2H2 | ZNF567 ZNF212 TRPS1 MECOM ZBTB12 ZNF25 ZNF568 ZNF284 ZNF10 ZNF677 ZNF23 ZNF547 ZNF33B ZNF852 ZNF592 ZNF408 ZNF483 CIZ1 ZNF432 ZNF534 ZNF578 ZNF701 ZNF84 ZNF468 ZKSCAN4 ZNF319 ZNF709 ZNF282 ZNF682 ZNF304 | 6.49e-17 | 805 | 106 | 30 | IPR007087 |
| Domain | ZnF_C2H2 | ZNF567 ZNF212 TRPS1 MECOM ZBTB12 ZNF25 ZNF568 ZNF284 ZNF10 ZNF677 ZNF23 ZNF547 ZNF33B ZNF852 ZNF592 ZNF408 ZNF483 CIZ1 ZNF432 ZNF534 ZNF578 ZNF701 ZNF84 ZNF468 ZKSCAN4 ZNF319 ZNF709 ZNF282 ZNF682 ZNF304 | 7.18e-17 | 808 | 106 | 30 | SM00355 |
| Domain | ZINC_FINGER_C2H2_2 | ZNF567 ZNF212 TRPS1 MECOM ZBTB12 ZNF25 ZNF568 ZNF284 ZNF10 ZNF677 ZNF23 ZNF547 ZNF33B ZNF852 ZNF592 ZNF408 ZNF483 ZNF432 ZNF534 ZNF578 ZNF701 ZNF84 ZNF468 ZKSCAN4 ZNF319 ZNF709 ZNF282 ZNF682 ZNF304 | 2.15e-16 | 775 | 106 | 29 | PS50157 |
| Domain | - | ZNF567 ZNF212 MECOM ZBTB12 ZNF25 ZNF568 ZNF284 ZNF10 ZNF677 ZNF23 ZNF547 ZNF33B ZNF852 ZNF408 ZNF483 ZNF432 ZNF534 ZNF578 ZNF701 ZNF84 ZNF468 ZKSCAN4 ZNF319 ZNF709 ZNF282 ZNF682 ZNF304 | 6.45e-16 | 679 | 106 | 27 | 3.30.160.60 |
| Domain | zf-C2H2_6 | ZNF567 ZNF212 MECOM ZNF25 ZNF568 ZNF284 ZNF10 ZNF677 ZNF852 ZNF408 ZNF483 ZNF432 ZNF578 ZNF701 ZNF84 ZNF468 ZKSCAN4 ZNF709 ZNF282 ZNF682 | 9.38e-16 | 314 | 106 | 20 | PF13912 |
| Domain | Znf_C2H2/integrase_DNA-bd | ZNF567 ZNF212 MECOM ZBTB12 ZNF25 ZNF568 ZNF284 ZNF10 ZNF677 ZNF23 ZNF547 ZNF33B ZNF852 ZNF408 ZNF483 ZNF432 ZNF534 ZNF578 ZNF701 ZNF84 ZNF468 ZKSCAN4 ZNF319 ZNF709 ZNF282 ZNF682 ZNF304 | 1.11e-15 | 694 | 106 | 27 | IPR013087 |
| Domain | Spectrin_repeat | 2.09e-05 | 29 | 106 | 4 | IPR002017 | |
| Domain | Spectrin/alpha-actinin | 3.12e-05 | 32 | 106 | 4 | IPR018159 | |
| Domain | SPEC | 3.12e-05 | 32 | 106 | 4 | SM00150 | |
| Domain | K_chnl_volt-dep_KCNQ2 | 3.19e-05 | 2 | 106 | 2 | IPR003947 | |
| Domain | KASH | 1.90e-04 | 4 | 106 | 2 | PF10541 | |
| Domain | KASH | 1.90e-04 | 4 | 106 | 2 | IPR012315 | |
| Domain | KASH | 1.90e-04 | 4 | 106 | 2 | PS51049 | |
| Domain | KASH | 1.90e-04 | 4 | 106 | 2 | SM01249 | |
| Domain | Actinin_actin-bd_CS | 2.90e-04 | 23 | 106 | 3 | IPR001589 | |
| Domain | Spectrin | 2.90e-04 | 23 | 106 | 3 | PF00435 | |
| Domain | ACTININ_2 | 2.90e-04 | 23 | 106 | 3 | PS00020 | |
| Domain | ACTININ_1 | 2.90e-04 | 23 | 106 | 3 | PS00019 | |
| Domain | K_chnl_volt-dep_KCNQ | 3.16e-04 | 5 | 106 | 2 | IPR003937 | |
| Domain | K_chnl_volt-dep_KCNQ_C | 3.16e-04 | 5 | 106 | 2 | IPR013821 | |
| Domain | KCNQ_channel | 3.16e-04 | 5 | 106 | 2 | PF03520 | |
| Domain | DUF3669_Znf | 4.72e-04 | 6 | 106 | 2 | IPR022137 | |
| Domain | DUF3669 | 4.72e-04 | 6 | 106 | 2 | PF12417 | |
| Domain | - | 1.12e-03 | 9 | 106 | 2 | 1.10.287.370 | |
| Domain | - | 1.39e-03 | 10 | 106 | 2 | 1.10.220.60 | |
| Domain | Grip | 1.70e-03 | 11 | 106 | 2 | SM00755 | |
| Domain | GRIP | 1.70e-03 | 11 | 106 | 2 | PF01465 | |
| Domain | Ran_BP1 | 2.03e-03 | 12 | 106 | 2 | PF00638 | |
| Domain | GRIP_dom | 2.03e-03 | 12 | 106 | 2 | IPR000237 | |
| Domain | GRIP | 2.03e-03 | 12 | 106 | 2 | PS50913 | |
| Domain | RANBD1 | 2.03e-03 | 12 | 106 | 2 | PS50196 | |
| Domain | RanBD | 2.39e-03 | 13 | 106 | 2 | SM00160 | |
| Domain | Ran_bind_dom | 2.39e-03 | 13 | 106 | 2 | IPR000156 | |
| Domain | CH | 6.01e-03 | 65 | 106 | 3 | SM00033 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION | ZNF567 PMS2 ZNF212 MAX DHX38 ZNF25 ZNF568 ZNF10 BMP2 ZNF677 NCOR1 ZNF23 ZNF547 ZNF33B MTOR ZNF483 TPX2 TNRC6A ZNF432 ZNF701 ZNF468 ZKSCAN4 ZNF709 ZNF282 ZNF682 ZNF304 | 4.94e-08 | 1387 | 83 | 26 | M734 |
| Pathway | REACTOME_GENE_EXPRESSION_TRANSCRIPTION | RGPD2 RANBP2 ZNF212 MAX DHX38 ZNF25 ZNF284 ZNF23 ZNF852 MTOR ZNF483 TPX2 TNRC6A ZKSCAN4 ZNF709 ZNF282 ZNF682 | 7.83e-05 | 1022 | 83 | 17 | MM15436 |
| Pubmed | SLK MRPS18B MAX TRPS1 MECOM PFDN1 ZNF284 NCOR1 SMC3 ZNF592 SYNE2 TPX2 TNRC6A PDCD11 HERC1 ZKSCAN4 ZNF319 CTTN ZNF709 | 9.61e-08 | 1429 | 109 | 19 | 35140242 | |
| Pubmed | RANBP2 PMS2 URI1 DSP DHX38 TRPS1 GPRIN3 PTPN21 NCOR1 SYNE2 TNRC6A GOLIM4 DMD HERC1 ZKSCAN4 | 1.02e-06 | 1049 | 109 | 15 | 27880917 | |
| Pubmed | 1.75e-06 | 181 | 109 | 7 | 37372979 | ||
| Pubmed | Multiple genes encoding zinc finger domains are expressed in human T cells. | 2.69e-06 | 31 | 109 | 4 | 2288909 | |
| Pubmed | 6.45e-06 | 12 | 109 | 3 | 25689854 | ||
| Pubmed | A direct physical interaction between Nanog and Sox2 regulates embryonic stem cell self-renewal. | 7.00e-06 | 146 | 109 | 6 | 23892456 | |
| Pubmed | 7.10e-06 | 418 | 109 | 9 | 34709266 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 11792814 | ||
| Pubmed | Nesprin-1 and nesprin-2 regulate endothelial cell shape and migration. | 9.73e-06 | 2 | 109 | 2 | 24931616 | |
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 37311604 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 22768332 | ||
| Pubmed | KCNQ2 and KCNQ5 form heteromeric channels independent of KCNQ3. | 9.73e-06 | 2 | 109 | 2 | 35320039 | |
| Pubmed | Syne-1 and Syne-2 play crucial roles in myonuclear anchorage and motor neuron innervation. | 9.73e-06 | 2 | 109 | 2 | 17267447 | |
| Pubmed | Nesprins: tissue-specific expression of epsilon and other short isoforms. | 9.73e-06 | 2 | 109 | 2 | 24718612 | |
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 24586179 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 23115080 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 33962210 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 17761684 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 31578382 | ||
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 31357026 | ||
| Pubmed | Muscle-specific deletion of SLK/Stk2 enhances p38 activity and myogenesis in mdx mice. | 2.91e-05 | 3 | 109 | 2 | 33259860 | |
| Pubmed | The inner nuclear membrane protein Sun1 mediates the anchorage of Nesprin-2 to the nuclear envelope. | 2.91e-05 | 3 | 109 | 2 | 16079285 | |
| Pubmed | The nuclear import of ribosomal proteins is regulated by mTOR. | 2.91e-05 | 3 | 109 | 2 | 25294810 | |
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 1639412 | ||
| Pubmed | Stem cell-like transcriptional reprogramming mediates metastatic resistance to mTOR inhibition. | 2.91e-05 | 3 | 109 | 2 | 27991928 | |
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 10878022 | ||
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 12890507 | ||
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 12408964 | ||
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 17462627 | ||
| Pubmed | Role of Nesprin-2 and RanBP2 in BICD2-associated brain developmental disorders. | 2.91e-05 | 3 | 109 | 2 | 36930595 | |
| Pubmed | Base excision repair intermediates induce p53-independent cytotoxic and genotoxic responses. | 2.91e-05 | 3 | 109 | 2 | 12882965 | |
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 33472039 | ||
| Pubmed | Nesprins anchor kinesin-1 motors to the nucleus to drive nuclear distribution in muscle cells. | 2.91e-05 | 3 | 109 | 2 | 25516977 | |
| Pubmed | The functional interactome landscape of the human histone deacetylase family. | 3.68e-05 | 289 | 109 | 7 | 23752268 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | TNIK RANBP2 SLK CDV3 DSP DHX38 FAM114A2 NSRP1 CRACD TPX2 CIZ1 CTTN | 3.78e-05 | 934 | 109 | 12 | 33916271 |
| Pubmed | The protein network surrounding the human telomere repeat binding factors TRF1, TRF2, and POT1. | 3.82e-05 | 197 | 109 | 6 | 20811636 | |
| Pubmed | 4.42e-05 | 22 | 109 | 3 | 31403225 | ||
| Pubmed | URI1 ZNF212 MAX TRPS1 ZNF25 NCOR1 ZMAT5 ZNF592 CIZ1 ZKSCAN4 ZNF282 | 4.83e-05 | 808 | 109 | 11 | 20412781 | |
| Pubmed | 5.82e-05 | 4 | 109 | 2 | 16648470 | ||
| Pubmed | 5.82e-05 | 4 | 109 | 2 | 30914432 | ||
| Pubmed | Outer nuclear membrane protein Kuduk modulates the LINC complex and nuclear envelope architecture. | 5.82e-05 | 4 | 109 | 2 | 28716842 | |
| Pubmed | Evi1 represses PTEN expression and activates PI3K/AKT/mTOR via interactions with polycomb proteins. | 5.82e-05 | 4 | 109 | 2 | 21289308 | |
| Pubmed | LINC complexes mediate the positioning of cone photoreceptor nuclei in mouse retina. | 5.82e-05 | 4 | 109 | 2 | 23071752 | |
| Pubmed | Nesprins, but not sun proteins, switch isoforms at the nuclear envelope during muscle development. | 5.82e-05 | 4 | 109 | 2 | 20108321 | |
| Pubmed | Mammalian target of rapamycin is essential for cardiomyocyte survival and heart development in mice. | 5.82e-05 | 4 | 109 | 2 | 25139234 | |
| Pubmed | 5.82e-05 | 4 | 109 | 2 | 19596800 | ||
| Pubmed | 5.82e-05 | 4 | 109 | 2 | 12566394 | ||
| Pubmed | RANBP2 ATP13A1 MRPS18B SYNE1 DHX38 TRPS1 CRACD PAXBP1 ZNF592 TPX2 TNRC6A CIZ1 GOLIM4 PDCD11 EDRF1 | 6.82e-05 | 1497 | 109 | 15 | 31527615 | |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | RGPD2 RANBP2 MRPS18B SYNE1 DHX38 TRPS1 PFDN1 CWC22 PHKA2 PAXBP1 SMC3 TPX2 CIZ1 | 6.84e-05 | 1155 | 109 | 13 | 20360068 |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | RANBP2 DSP MYO9B MAX TRPS1 MECOM PHKA2 CRACD NCOR1 SMC3 TPX2 | 8.17e-05 | 857 | 109 | 11 | 25609649 |
| Pubmed | LINC complexes form by binding of three KASH peptides to domain interfaces of trimeric SUN proteins. | 9.67e-05 | 5 | 109 | 2 | 22632968 | |
| Pubmed | 9.67e-05 | 5 | 109 | 2 | 8464732 | ||
| Pubmed | Interactions of the DNA mismatch repair proteins MLH1 and MSH2 with c-MYC and MAX. | 9.67e-05 | 5 | 109 | 2 | 12584560 | |
| Pubmed | The contribution of Kv7 channels to pregnant mouse and human myometrial contractility. | 9.67e-05 | 5 | 109 | 2 | 20132415 | |
| Pubmed | Dual phosphorylations underlie modulation of unitary KCNQ K(+) channels by Src tyrosine kinase. | 9.67e-05 | 5 | 109 | 2 | 15304482 | |
| Pubmed | 9.67e-05 | 5 | 109 | 2 | 15159385 | ||
| Pubmed | 9.67e-05 | 5 | 109 | 2 | 18396275 | ||
| Pubmed | Hypoxia induces BMP-2 expression via ILK, Akt, mTOR, and HIF-1 pathways in osteoblasts. | 9.67e-05 | 5 | 109 | 2 | 20232298 | |
| Pubmed | 9.89e-05 | 234 | 109 | 6 | 36243803 | ||
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | 1.01e-04 | 588 | 109 | 9 | 38580884 | |
| Pubmed | 1.10e-04 | 149 | 109 | 5 | 25184681 | ||
| Pubmed | 1.17e-04 | 151 | 109 | 5 | 17043677 | ||
| Pubmed | Structural Analysis of Different LINC Complexes Reveals Distinct Binding Modes. | 1.45e-04 | 6 | 109 | 2 | 33058875 | |
| Pubmed | 1.45e-04 | 6 | 109 | 2 | 18827015 | ||
| Pubmed | 1.45e-04 | 6 | 109 | 2 | 12032157 | ||
| Pubmed | 1.45e-04 | 6 | 109 | 2 | 22696681 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | RANBP2 SLK NRDC DSP DYNC2H1 ATP13A1 SYNE1 DHX38 CWC22 PAXBP1 SMC3 MTOR PDCD11 CTTN | 1.49e-04 | 1425 | 109 | 14 | 30948266 |
| Pubmed | PMS2 NRDC ZNF212 DHX38 GALNT7 ANKRD6 ZNF568 FEM1B TAOK3 PAXBP1 ARHGEF3 HERC1 | 1.54e-04 | 1084 | 109 | 12 | 11544199 | |
| Pubmed | 1.68e-04 | 493 | 109 | 8 | 15368895 | ||
| Pubmed | PMS2 DSP ATP13A1 SYNE1 ADAM9 TRPS1 ANKRD6 TRIM66 ZNF592 KCNN1 KCNQ2 ZNF84 CTTN | 1.97e-04 | 1285 | 109 | 13 | 35914814 | |
| Pubmed | 2.02e-04 | 645 | 109 | 9 | 25281560 | ||
| Pubmed | 2.02e-04 | 7 | 109 | 2 | 9037092 | ||
| Pubmed | Genomic organization, expression, and localization of murine Ran-binding protein 2 (RanBP2) gene. | 2.02e-04 | 7 | 109 | 2 | 11353387 | |
| Pubmed | 2.02e-04 | 7 | 109 | 2 | 30944974 | ||
| Pubmed | 2.02e-04 | 7 | 109 | 2 | 38838144 | ||
| Pubmed | Retina-specifically expressed novel subtypes of bovine cyclophilin. | 2.02e-04 | 7 | 109 | 2 | 7559465 | |
| Pubmed | Mst1, RanBP2 and eIF4G are new markers for in vivo PI3K activation in murine and human prostate. | 2.02e-04 | 7 | 109 | 2 | 17372272 | |
| Pubmed | 2.02e-04 | 7 | 109 | 2 | 38657106 | ||
| Pubmed | 2.02e-04 | 7 | 109 | 2 | 21205196 | ||
| Pubmed | 2.02e-04 | 7 | 109 | 2 | 18949001 | ||
| Pubmed | 2.02e-04 | 7 | 109 | 2 | 25187515 | ||
| Pubmed | 2.02e-04 | 7 | 109 | 2 | 8603673 | ||
| Pubmed | 2.02e-04 | 7 | 109 | 2 | 26632511 | ||
| Pubmed | 2.02e-04 | 7 | 109 | 2 | 24403063 | ||
| Pubmed | 2.02e-04 | 7 | 109 | 2 | 23818861 | ||
| Pubmed | 2.02e-04 | 7 | 109 | 2 | 23536549 | ||
| Pubmed | 2.02e-04 | 7 | 109 | 2 | 12191015 | ||
| Pubmed | 2.02e-04 | 7 | 109 | 2 | 22821000 | ||
| Pubmed | 2.02e-04 | 7 | 109 | 2 | 20682751 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | RANBP2 DSP CWC22 NSRP1 NCOR1 PAXBP1 TPX2 CIZ1 PDCD11 ZKSCAN4 CTTN | 2.08e-04 | 954 | 109 | 11 | 36373674 |
| Pubmed | TNIK SLK NRDC DSP ADAM9 GALNT7 NCOR1 NAA35 SMC3 SYNE2 TPX2 GOLIM4 PDCD11 | 2.15e-04 | 1297 | 109 | 13 | 33545068 | |
| Pubmed | TNIK DYNC2H1 ATP13A1 MRPS18B SYNE1 SNAP47 NSRP1 NAA35 PAXBP1 SYNE2 CIZ1 PDCD11 AKAP11 EDRF1 | 2.31e-04 | 1487 | 109 | 14 | 33957083 | |
| Pubmed | Mutation of ARHGAP9 in patients with coronary spastic angina. | 2.33e-04 | 38 | 109 | 3 | 19911011 | |
| Pubmed | The nucleoporin RanBP2 tethers the cAMP effector Epac1 and inhibits its catalytic activity. | 2.69e-04 | 8 | 109 | 2 | 21670213 | |
| Pubmed | 2.69e-04 | 8 | 109 | 2 | 27412403 | ||
| Pubmed | Mice lacking Ran binding protein 1 are viable and show male infertility. | 2.69e-04 | 8 | 109 | 2 | 21310149 | |
| Pubmed | The distribution of phosphorylated SR proteins and alternative splicing are regulated by RANBP2. | 2.69e-04 | 8 | 109 | 2 | 22262462 | |
| Pubmed | Zap70 and downstream RanBP2 are required for the exact timing of the meiotic cell cycle in oocytes. | 2.69e-04 | 8 | 109 | 2 | 28745977 | |
| Pubmed | Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer. | 2.94e-04 | 184 | 109 | 5 | 32908313 | |
| Pubmed | 3.06e-04 | 407 | 109 | 7 | 12693553 | ||
| Interaction | TRIM28 interactions | TNIK ZNF567 RANBP2 SLK URI1 MRPS18B DHX38 ZNF25 ZNF284 ZNF10 NCOR1 ZNF33B SMC3 MTOR ZNF483 ZNF432 PDCD11 ZNF701 ZNF84 ZNF468 ZNF682 ZNF304 | 1.11e-05 | 1474 | 109 | 22 | int:TRIM28 |
| Interaction | ERMAP interactions | 1.50e-05 | 28 | 109 | 4 | int:ERMAP | |
| Interaction | DISC1 interactions | TNIK ATP13A1 PPFIA4 SYNE1 DHX38 ITGA1 NSRP1 KCNQ5 SMC3 GCC1 DMD | 2.11e-05 | 429 | 109 | 11 | int:DISC1 |
| Cytoband | 19q13.41 | 1.26e-06 | 78 | 109 | 5 | 19q13.41 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19q13 | ZNF567 PLEKHG2 ZNF568 ZNF284 ZNF677 ZNF547 ZNF432 ZNF534 ZNF578 ZNF701 ZNF468 ZNF304 | 2.76e-05 | 1192 | 109 | 12 | chr19q13 |
| Cytoband | 10q24.33 | 3.63e-04 | 12 | 109 | 2 | 10q24.33 | |
| Cytoband | 3q26.2 | 1.89e-03 | 27 | 109 | 2 | 3q26.2 | |
| Cytoband | 15q22 | 2.17e-03 | 29 | 109 | 2 | 15q22 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZNF567 ZNF212 TRPS1 MECOM ZBTB12 ZNF25 ZNF568 ZNF284 ZNF10 ZNF677 ZNF23 ZNF547 ZNF33B ZNF852 ZNF592 ZNF408 ZNF483 ZNF432 ZNF534 ZNF578 ZNF701 ZNF84 ZNF468 ZKSCAN4 ZNF319 ZNF709 ZNF282 ZNF682 ZNF304 | 1.55e-20 | 718 | 81 | 29 | 28 |
| GeneFamily | Spectrin repeat containing nuclear envelope family | 1.18e-04 | 4 | 81 | 2 | 1252 | |
| GeneFamily | Prefoldin subunits | 5.45e-04 | 8 | 81 | 2 | 956 | |
| GeneFamily | Zinc fingers C2H2-type|PR/SET domain family | 2.58e-03 | 17 | 81 | 2 | 1197 | |
| Coexpression | CHIBA_RESPONSE_TO_TSA_DN | 1.60e-06 | 21 | 109 | 4 | M12459 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | RANBP2 CDV3 DYNC2H1 MECOM ZBTB12 ANKRD6 CWC22 NSRP1 CRACD NCOR1 VAC14 ZNF23 CCNYL1 SMC3 SYNE2 TPX2 DMD PHF21B | 1.58e-06 | 989 | 105 | 18 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | RANBP2 MECOM ZBTB12 NSRP1 NCOR1 ZNF23 CCNYL1 SMC3 SYNE2 TPX2 | 3.32e-06 | 311 | 105 | 10 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500_k-means-cluster#5 | 2.02e-05 | 232 | 105 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | 3.67e-05 | 328 | 105 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3 | 4.78e-05 | 192 | 105 | 7 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | RANBP2 DYNC2H1 ZBTB12 ANKRD6 NSRP1 CRACD NCOR1 ZNF23 SMC3 SYNE2 TPX2 GOLIM4 DMD CTTN | 5.97e-05 | 831 | 105 | 14 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000 | SLK CDV3 URI1 NWD1 SYNE1 TRPS1 MECOM PLEKHG2 CWC22 NSRP1 TMEM132C ZNF23 PAXBP1 SMC3 SYNE2 | 1.04e-04 | 989 | 105 | 15 | Facebase_RNAseq_e10.5_Maxillary Arch_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500 | 1.67e-04 | 493 | 105 | 10 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 4.48e-07 | 192 | 108 | 7 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_T|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.97e-07 | 195 | 108 | 7 | 4b9663509cc5e3f409f6d0d37640cb301a827d98 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.71e-06 | 170 | 108 | 6 | 876b84740e15399bfff2b9c7f0b80fd759bbdb3f | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.71e-06 | 170 | 108 | 6 | 1f8738acf439d893880db7e1fdc9b3615ca00c39 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 3.83e-06 | 171 | 108 | 6 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | NS-critical-LOC-Lymphoid-NK|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.83e-06 | 171 | 108 | 6 | adda76991d9b150bb8ccf3989b7cbbf41843cf0b | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.52e-06 | 176 | 108 | 6 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | severe-CD8+_T_naive|severe / disease stage, cell group and cell class | 5.15e-06 | 180 | 108 | 6 | 94fe530367b170777f4051a4034cff06d80dbb83 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.23e-06 | 191 | 108 | 6 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.23e-06 | 191 | 108 | 6 | 09db184cb90fe282a14474d7217068c58092c6f8 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.23e-06 | 191 | 108 | 6 | 973117730d6ba5f127e7a0bfabfd0ff2ca7ac131 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.69e-05 | 154 | 108 | 5 | ec920cae12ea1d14b6c973f6e903f895f80e3c50 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8|bone_marrow / Manually curated celltypes from each tissue | 3.93e-05 | 156 | 108 | 5 | 1545169694f686d28648a68b552c2ae606599d66 | |
| ToppCell | facs-Thymus-Thymus_Flowthrough-18m-Epithelial|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.17e-05 | 158 | 108 | 5 | 12661763d1c309106801cb710c04cd2b62d16cba | |
| ToppCell | facs-Thymus-Thymus_Flowthrough-18m-Epithelial-epithelial_cell_of_thymus|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.17e-05 | 158 | 108 | 5 | e7db50d6dfaf7280a73a0d5b5aa4f43ea2762d72 | |
| ToppCell | facs-Thymus-Thymus_Flowthrough-18m-Epithelial-TECs|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.17e-05 | 158 | 108 | 5 | 0792c39e6fc0745095af7812de2d50949540d60f | |
| ToppCell | facs-Marrow-T-cells-3m-Hematologic-MPP_Fraction_B_+_C|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.91e-05 | 170 | 108 | 5 | d70aaa0f4e5034bb9f61b832b5f9123870936d3c | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.35e-05 | 178 | 108 | 5 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8|Liver / Manually curated celltypes from each tissue | 7.95e-05 | 181 | 108 | 5 | f2315414e714ac86211546a935660c4be6e85f1b | |
| ToppCell | droplet-Liver-nan-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.37e-05 | 183 | 108 | 5 | 709a486154b3157427deb3b8886b63ac39ea42dd | |
| ToppCell | droplet-Liver-nan-3m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.37e-05 | 183 | 108 | 5 | dc06f19f6f80f4c7f13f1f990c1fe0f91ba64ea7 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.37e-05 | 183 | 108 | 5 | 3c516fe5083f02bad1f464ed284010b4131a833c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.37e-05 | 183 | 108 | 5 | 9c2689d76fc6d30f5ab093428aa669d0a98953cf | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.37e-05 | 183 | 108 | 5 | 667717366cb181b8a04a347e64f0f5a4dfc6ee7f | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.59e-05 | 184 | 108 | 5 | 7294b379ce4cb8fa75e432559082f93cd106aaf5 | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-T_lymphocytic-effector_CD4-positive,_alpha-beta_T_cell|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 9.27e-05 | 187 | 108 | 5 | e61c1755531469dd3850c9740474b5ad4e0499c1 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 9.50e-05 | 188 | 108 | 5 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c07-TYROBP|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.74e-05 | 189 | 108 | 5 | bed43041e6f8ba19787150a6aaa492f2656135d9 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.74e-05 | 189 | 108 | 5 | 7ab1cfc1657277858339f7258a0c4ae9cb42fdf8 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.74e-05 | 189 | 108 | 5 | 203c80030df08ae112f9ae4043709f455d87ce89 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells-CD8_T_cells_L.1.1.4.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.99e-05 | 190 | 108 | 5 | d153a0bdedcd6865e6ee19575234a78b5d859ff1 | |
| ToppCell | PCW_13-14|World / Celltypes from embryonic and fetal-stage human lung | 9.99e-05 | 190 | 108 | 5 | 62a3ec1ae0829602b0569cc051210551644f1d46 | |
| ToppCell | COPD-Lymphoid-T_Regulatory|Lymphoid / Disease state, Lineage and Cell class | 1.02e-04 | 191 | 108 | 5 | 3ae18bc4e3dff49b5d5958da8ebc3f747274b69c | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.02e-04 | 191 | 108 | 5 | 08042952431ca1a6fd7dfc13f36eb28643979598 | |
| ToppCell | RA-09._Endothelium_I|World / Chamber and Cluster_Paper | 1.02e-04 | 191 | 108 | 5 | c8a0c2af119bc34a8f694a7d30642f28002c84b9 | |
| ToppCell | RA-09._Endothelium_I|RA / Chamber and Cluster_Paper | 1.05e-04 | 192 | 108 | 5 | 8a1b1c3e83a68ad74f8f4eb00455c9e41aa57cfc | |
| ToppCell | severe-low-quality_cells|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.07e-04 | 193 | 108 | 5 | 9337bc93e3904c7fc7c93c328518bcd6453b1e8c | |
| ToppCell | RV-10._Endothelium_II|World / Chamber and Cluster_Paper | 1.07e-04 | 193 | 108 | 5 | 2531266bc57339d4e2b22a88817008e32b8c1598 | |
| ToppCell | LA-09._Endothelium_I|World / Chamber and Cluster_Paper | 1.13e-04 | 195 | 108 | 5 | fc95457a298b5d0dab687d9ee7e225a7f7b9a0d4 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c04-COTL1|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.13e-04 | 195 | 108 | 5 | 14a6466524c22920daa622fbc710daf1defb46c3 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.16e-04 | 196 | 108 | 5 | c9fb81a0578db6d278b8582d7b3add6c407e6dcf | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.18e-04 | 197 | 108 | 5 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | mild-low-quality_cells|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.18e-04 | 197 | 108 | 5 | e4331969bd911d1ebb5453f40a7057297b5389b4 | |
| ToppCell | LA-09._Endothelium_I|LA / Chamber and Cluster_Paper | 1.18e-04 | 197 | 108 | 5 | ab6d1ab586a188597a39854ef980b8955ebcc645 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-IPC_like|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 1.21e-04 | 198 | 108 | 5 | 6d12ecaa9532c134d9c4562534dcb59a6420b4d3 | |
| ToppCell | T_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 1.21e-04 | 198 | 108 | 5 | 1ca6cd8e75891fdfaddbb4a7342eec9ca4d11e5d | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-IPC_like-IPs_and_early_cortical_neurons|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 1.21e-04 | 198 | 108 | 5 | 7943e4f67c3d6efb5c8b00aa0ff3cfe7be10c48d | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.24e-04 | 199 | 108 | 5 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | Sepsis-Leuk-UTI-Lymphocyte-T/NK-dn_T|Leuk-UTI / Disease, condition lineage and cell class | 1.24e-04 | 199 | 108 | 5 | aa4d8ce8994e5032a33d5cc68c482882147cdc3b | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 1.24e-04 | 199 | 108 | 5 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 1.24e-04 | 199 | 108 | 5 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.24e-04 | 199 | 108 | 5 | 30d3e8c0681ec11f86dd38c5f48d21187a1b4f90 | |
| ToppCell | (01)_IL1RL1+-(2)_GFP_FOXI1|(01)_IL1RL1+ / shred by cell type by condition | 1.24e-04 | 199 | 108 | 5 | a2f7d0cabf35b80fe239fae34a77bf9344d5d743 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.27e-04 | 200 | 108 | 5 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-SULF1--L4-6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.27e-04 | 200 | 108 | 5 | 4a426ef88376d8bb2b9dc50aa06e7b9fc50ecc9c | |
| ToppCell | Sepsis-Int-URO-Lymphocyte-T/NK-gd_T|Int-URO / Disease, condition lineage and cell class | 1.27e-04 | 200 | 108 | 5 | d382ee690e370886009eff42d14952d44a6d4d18 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-SULF1|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.27e-04 | 200 | 108 | 5 | fbeee1c16ac0a7fe28d90491c8b079f21ce80bdc | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-SULF1-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.27e-04 | 200 | 108 | 5 | c6eda342ea0cb37d71d89dbb8d11e819e0745172 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 3.75e-07 | 50 | 62 | 6 | GAVISH_3CA_MALIGNANT_METAPROGRAM_4_CHROMATIN | |
| Disease | Autosomal dominant Emery-Dreifuss muscular dystrophy | 7.63e-05 | 4 | 106 | 2 | cv:CN293514 | |
| Disease | Mammary Carcinoma, Human | 1.19e-04 | 525 | 106 | 9 | C4704874 | |
| Disease | Mammary Neoplasms, Human | 1.19e-04 | 525 | 106 | 9 | C1257931 | |
| Disease | Mammary Neoplasms | 1.22e-04 | 527 | 106 | 9 | C1458155 | |
| Disease | Autosomal Recessive Emery-Dreifuss Muscular Dystrophy | 1.27e-04 | 5 | 106 | 2 | C1450051 | |
| Disease | Autosomal Dominant Emery-Dreifuss Muscular Dystrophy (disorder) | 1.27e-04 | 5 | 106 | 2 | C0410190 | |
| Disease | Malignant neoplasm of breast | DYNC2H1 SYNE1 MECOM ZNF25 BMP2 NCOR1 MTOR SYNE2 ANGPTL4 ZNF432 GOLIM4 LGR6 DMD | 1.27e-04 | 1074 | 106 | 13 | C0006142 |
| Disease | Breast Carcinoma | 1.43e-04 | 538 | 106 | 9 | C0678222 | |
| Disease | Emery-Dreifuss muscular dystrophy | 1.90e-04 | 6 | 106 | 2 | cv:C0410189 | |
| Disease | stearoyl sphingomyelin (d18:1/18:0) measurement | 1.90e-04 | 6 | 106 | 2 | EFO_0800611 | |
| Disease | Muscular Dystrophy, Emery-Dreifuss | 1.90e-04 | 6 | 106 | 2 | C0410189 | |
| Disease | Colorectal Carcinoma | 2.23e-04 | 702 | 106 | 10 | C0009402 | |
| Disease | X-Linked Emery-Dreifuss Muscular Dystrophy | 2.65e-04 | 7 | 106 | 2 | C0751337 | |
| Disease | long QT syndrome (implicated_via_orthology) | 5.65e-04 | 10 | 106 | 2 | DOID:2843 (implicated_via_orthology) | |
| Disease | Emery-Dreifuss muscular dystrophy (implicated_via_orthology) | 8.24e-04 | 12 | 106 | 2 | DOID:11726 (implicated_via_orthology) | |
| Disease | developmental and epileptic encephalopathy (implicated_via_orthology) | 9.72e-04 | 13 | 106 | 2 | DOID:0112202 (implicated_via_orthology) | |
| Disease | non-high density lipoprotein cholesterol measurement | 1.09e-03 | 713 | 106 | 9 | EFO_0005689 | |
| Disease | Myopia | 1.30e-03 | 15 | 106 | 2 | C0027092 | |
| Disease | ovarian neoplasm | 1.41e-03 | 134 | 106 | 4 | C0919267 | |
| Disease | Malignant neoplasm of ovary | 1.53e-03 | 137 | 106 | 4 | C1140680 | |
| Disease | Malignant neoplasm of endometrium | 1.88e-03 | 18 | 106 | 2 | C0007103 | |
| Disease | Myeloid Leukemia | 1.88e-03 | 18 | 106 | 2 | C0023470 | |
| Disease | Leukemia, Monocytic, Chronic | 1.88e-03 | 18 | 106 | 2 | C0023466 | |
| Disease | Carcinoma in situ of endometrium | 1.88e-03 | 18 | 106 | 2 | C0346191 | |
| Disease | gastric ulcer | 2.57e-03 | 21 | 106 | 2 | EFO_0009454 | |
| Disease | white matter microstructure measurement | 2.89e-03 | 390 | 106 | 6 | EFO_0005674 | |
| Disease | Colorectal Neoplasms | 3.30e-03 | 277 | 106 | 5 | C0009404 | |
| Disease | chronic obstructive pulmonary disease | 3.42e-03 | 688 | 106 | 8 | EFO_0000341 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DHKKQDHRVQDFLQR | 226 | Q9NR81 | |
| HKVAQQQRHLEKQHL | 121 | Q9BY76 | |
| KELGHLTHQQAREVK | 691 | Q9HD20 | |
| EHHQEADKKRQSKRN | 1416 | Q9UKA4 | |
| QRQFEHILKNEHIKN | 101 | Q8N4G2 | |
| DHNKQLESQLHRLRQ | 3581 | P11532 | |
| AHLEEKQGVSKRHVR | 231 | P12643 | |
| QTDVREKRKSNHLNH | 96 | Q8N7R7 | |
| RHKNRGRDEVSKNQA | 221 | Q9UKY7 | |
| QQHSDTEKHEGEKRQ | 481 | Q9Y2G4 | |
| RLGQQLRHDDSKQHT | 321 | Q149M9 | |
| QHEINTLRAQEKHGL | 556 | P49792 | |
| RGHEKREDQHQQKQS | 311 | Q9H0G5 | |
| QRHVRNIHNKEKPFK | 956 | Q03112 | |
| QTNLDRHLKKHENGN | 981 | Q03112 | |
| RKNHTHQQDIDDLKR | 76 | P61244 | |
| HRCQKLEEIGLQHNR | 371 | Q9HBX8 | |
| QVGDEHLRKQHRVLA | 1041 | Q3B7T1 | |
| SQRQIEEQHHHKGRL | 466 | O75335 | |
| KEIAAKLNIHRVHGQ | 1816 | Q2LD37 | |
| RKHQRKFLQAIHQAQ | 421 | Q92952 | |
| EQHRQKHFEKRRNPA | 356 | Q9NR82 | |
| ESQHQITEGKRKNHE | 2476 | Q15751 | |
| DRKQKERRQEHGHQE | 741 | Q9HCG8 | |
| DIKNHIHEVQKSLRN | 471 | Q8N187 | |
| LHLRQKGNRNTHKDL | 371 | Q9UK73 | |
| DIQIEQLNRTKKHAH | 31 | O60925 | |
| QEQHRQKHFEKRRNP | 321 | O43526 | |
| QGDAQHKQHQRLREV | 231 | Q96PG2 | |
| HKQHQRLREVKQVAP | 236 | Q96PG2 | |
| HKTNRQQHEKHLQSR | 406 | Q9Y5B6 | |
| DGESHDNHRLKKVIQ | 281 | P56199 | |
| QPIQENKGHVKREHE | 796 | Q2PPJ7 | |
| RVKEHGTHQQLLAQK | 1256 | P21439 | |
| KQLNRGLVHAERQSH | 456 | Q16825 | |
| RKAHQDIHTQLQDVK | 186 | O00461 | |
| KIQNHGHRVLQRLEQ | 341 | Q86WN1 | |
| EQAHRGNKQISKERA | 181 | Q8NCM8 | |
| RKQKHRLEVEVHQLQ | 671 | Q96CN9 | |
| NNHNPKGRLRNQHKV | 1211 | Q6WRI0 | |
| RRINKAKNEQEHHAG | 86 | Q86SF2 | |
| SKKHRRLAQDPQHEQ | 171 | Q6ZU35 | |
| KQAHLRNEHFQKAIE | 1676 | P15924 | |
| QAEGKEHIIHLERNK | 71 | Q13443 | |
| ENKIESHRHELQGQK | 486 | Q9NRY5 | |
| NHLQRQIREHEKLIK | 711 | Q6ZVF9 | |
| RKNEDKLNHHQRIGL | 126 | P06746 | |
| AENNHIKDLLRKHGV | 446 | P46019 | |
| HQNQARDEKKKLRHA | 1806 | P42345 | |
| EKVQNKHLEVRHQRS | 756 | Q08AM6 | |
| KNQAERKADNHTAHR | 36 | Q96M34 | |
| LDHFRRKGINQHVQN | 516 | Q9UQE7 | |
| KQAVGLVEHRKEHVR | 111 | O94763 | |
| LHDNKIIHRDLKAGN | 146 | Q9H2G2 | |
| KRLEDTARVLHHQGQ | 176 | Q5SQN1 | |
| QEKRLKQQHRIGDQA | 7041 | Q8NF91 | |
| EIKNHASDRRQKGQH | 816 | Q8N3T6 | |
| NLHQHLKQEQEGVER | 4066 | Q8WXH0 | |
| QHEINTLRAQEKHGL | 556 | P0DJD1 | |
| EHLDHRLREKVKQQN | 151 | A5D8V7 | |
| RRHNLDNLLQQHKQK | 671 | O75376 | |
| IRRKQEQHVHNEKSV | 86 | O43930 | |
| RISKHKENLQHTQAE | 581 | Q9H2K8 | |
| KNLSQDQEHGRKAHK | 271 | Q02383 | |
| HQGRIKNAREAHSQI | 66 | O00327 | |
| DLIQHRRTQDHKIAK | 666 | Q9ULV3 | |
| KLRKGSEHQAIVQHL | 921 | Q14690 | |
| NLIVHQRTHKGENIE | 631 | Q8N184 | |
| HIQRGLHRNNAQVEK | 1261 | Q9UHF7 | |
| QHKRLTQAIQKARDH | 146 | Q9Y676 | |
| QHKVIHRDIKGQNVL | 146 | Q9UKE5 | |
| RRHLKEQHGKTTAEN | 431 | Q9Y330 | |
| RHDQRHAGNKPIKDQ | 141 | Q96N58 | |
| QKSNLERHKIIHTGE | 466 | Q96N58 | |
| KSQLTQHQRIHIGEK | 621 | Q06732 | |
| RKENLITHQKIHTGE | 261 | Q3ZCX4 | |
| QRQNLLEHEKIHTGE | 541 | Q3ZCX4 | |
| IQIHGHNRARQRDKL | 436 | Q5VZE5 | |
| RHQNGDLKKQLHERQ | 16 | Q96EK2 | |
| HKLRENVFQEHQTLK | 56 | Q14247 | |
| NSLRKHIRNNHDTVK | 1026 | Q92610 | |
| QRDLKEHQVVHSGAR | 421 | Q9H9D4 | |
| SHLNEHKRVQRGEKS | 466 | O95780 | |
| QHKFHQLKQEARRDA | 196 | Q8NCL8 | |
| NSNLQRHRKIHTGEK | 491 | Q76KX8 | |
| LKHEPRKNNIDTHAR | 351 | O43847 | |
| REQHLHKQKQKRISA | 351 | Q92620 | |
| NDQQRRQLGKSHLHR | 316 | A8MT19 | |
| NIEDHKNQGRKLRSH | 51 | Q8N972 | |
| AKRIKQLHHEAQQSE | 626 | P54278 | |
| KSNLINHQRIHTGEK | 331 | P51523 | |
| QFANLTRHQKIHIEK | 526 | Q86XU0 | |
| KNDLIKHQRIHVGEE | 501 | P21506 | |
| REHLNKHQGVHAREQ | 526 | Q9P2F9 | |
| NRNLIDHQRTHTGEK | 311 | Q6ZMS4 | |
| SKNEDLIRHQKIHTR | 156 | P17030 | |
| HLLRHQRIHGDKNVQ | 446 | Q969J2 | |
| LHQHQKEQIREKLSR | 121 | Q8IVP9 | |
| KRNLIVHQRNHTGEK | 301 | O94892 | |
| DRSFQDNLHNRKKHL | 11 | Q9UDW3 | |
| LQHQKIHQRERGGLA | 471 | Q9UDV6 | |
| EHQKRQKIHLGDRSQ | 376 | Q8TF39 | |
| KHRHLLQAKNQEEKR | 386 | Q9H7P9 | |
| RKDTLVQHQKIHTGE | 486 | Q9HCX3 | |
| RHDQRHAGNKPIKNE | 191 | Q9NV72 | |
| NTKLIQHQRIHTGEK | 376 | P17027 | |
| RIFEVKHQHRKVENQ | 136 | O15016 | |
| HDQRHAGNKRIKDQL | 126 | Q5VIY5 | |
| DRVKNVLKSHQAHQR | 381 | Q9NWH7 | |
| RHQEHKQLLKRGQHF | 141 | Q8NDV7 | |
| KEHLQNHQRLHTGER | 586 | Q9UDV7 | |
| NSQLREHQRIHTGEK | 271 | Q2VY69 | |
| HFRTDERIKQHPKNQ | 261 | Q9ULW0 | |
| HLHNNRIIHRDVKGN | 146 | Q8WXR4 | |
| RRQRGLEHVKFQNKH | 1151 | Q13459 |